Development of Atrial Flutter After Initiation of Clozapine and Successful Rechallenge Without Recurrence.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of clinical psychopharmacology"
DOI: 10.1097/jcp.0000000000000718
Abstract: To the Editors: C lozapine remains the criterion standard treatment for patients with schizophreniawho have previously failed adequate trials of 2 other antipsychotics. In addition to its designation for treatment-resistant schizophrenia, it has also shown… read more here.
Keywords: clozapine; treatment; development atrial; atrial flutter ... See more keywords
Successful rechallenge after clozapine-associated myocarditis
Sign Up to like & getrecommendations! Published in 2022 at "BMJ Case Reports"
DOI: 10.1136/bcr-2022-248909
Abstract: Clozapine is a highly effective medication used in management of treatment-resistant schizophrenia. Clozapine-associated myocarditis (CAM) is a rare but increasingly recognised complication of clozapine titration. Following an episode of CAM, clinicians can face a challenging… read more here.
Keywords: clozapine associated; rechallenge clozapine; clozapine; associated myocarditis ... See more keywords
Successful rechallenge for severe lichenoid drug reaction to pembrolizumab presenting as “toxic epidermal necrolysis-like”
Sign Up to like & getrecommendations! Published in 2022 at "European Journal of Dermatology"
DOI: 10.1684/ejd.2022.4378
Abstract: 8. Gallo G, Mastorino L, Tonella L, Ribero S, Quaglino P. Alopecia areata after COVID-19 vaccination. Clin Exp Vaccine Res 2022; 11: 129-32. 9. Aryanian Z, Balighi K, Hatami P, Afshar ZM, Mohandesi NA. The… read more here.
Keywords: drug reaction; severe lichenoid; reaction pembrolizumab; rechallenge severe ... See more keywords